We analyzed immunohistochemically the expression of CD24 and spliced variants of CD44v5 and v9 in invasive micropapillary carcinoma (IMPC) of the breast that is a rather aggressive tumor characterized by alteration of cells adhesion molecules, early lymph node metastases and poor prognosis. We analyzed 31 high-grade IMPCs and compared their expression to 22 high grade (G3) invasive ductal carcinomas of the breast (IDCs). We found a higher expression of CD24 in high-grade IMPCs with a peculiar inverted apical localization, compared to IDCs, showing a strong cytoplasmic staining; normal breast tissue resulted completely negative. IMPCs showed reduced expression of CD44v5 and CD44v9 compared with IDCs, but without a statistical significant dif...
Objective: Invasive micropapillary carcinoma of the breast is a distinct variant of breast cancer. I...
<p>A, DAPI; B, DAPI and CD24 (red); C, DAPI and CD44 (green); D, merged images. The composite image ...
This study aimed to identify the CD24 and CD44 immunophenotypes within invasive ductal breast carcin...
We analyzed immunohistochemically the expression of CD24 and spliced variants of CD44v5 and v9 in in...
A subpopulation of breast cancer cells with cluster of differentiation (CD)44-positive and CD24-nega...
Breast cancer cells with the CD44+/CD24- phenotype have been reported to be tumourigenic due to thei...
Breast cancer cells with the CD44+/CD24- phenotype have been reported to be tumourigenic due to thei...
The role of the expression of CD44 and CD24 in breast cancer (BC) has been explored in many laborato...
The presence of tumor-initiating cells (CD44(+)/CD24(-)) in solid tumors has been reported as a poss...
Introduction Human breast tumors are heterogeneous and consist of phenotypically diverse cells. Brea...
Abstract—In this study, we tried to explore the characteristics of cancer stem cell-related markers ...
[[abstract]]Ductal carcinoma in situ (DCIS) transition to invasive tumor is an important issue for b...
CD44 is known as an adhesion molecule which is involved in lymphocyte activation and lymphocyte homi...
Cancer stem cells (CSCs) have been defined as 'a cell within a tumor that possesses the capacity to ...
Introduction A subpopulation (CD44+/CD24-) of breast cancer cells has been reported to have stem/pr...
Objective: Invasive micropapillary carcinoma of the breast is a distinct variant of breast cancer. I...
<p>A, DAPI; B, DAPI and CD24 (red); C, DAPI and CD44 (green); D, merged images. The composite image ...
This study aimed to identify the CD24 and CD44 immunophenotypes within invasive ductal breast carcin...
We analyzed immunohistochemically the expression of CD24 and spliced variants of CD44v5 and v9 in in...
A subpopulation of breast cancer cells with cluster of differentiation (CD)44-positive and CD24-nega...
Breast cancer cells with the CD44+/CD24- phenotype have been reported to be tumourigenic due to thei...
Breast cancer cells with the CD44+/CD24- phenotype have been reported to be tumourigenic due to thei...
The role of the expression of CD44 and CD24 in breast cancer (BC) has been explored in many laborato...
The presence of tumor-initiating cells (CD44(+)/CD24(-)) in solid tumors has been reported as a poss...
Introduction Human breast tumors are heterogeneous and consist of phenotypically diverse cells. Brea...
Abstract—In this study, we tried to explore the characteristics of cancer stem cell-related markers ...
[[abstract]]Ductal carcinoma in situ (DCIS) transition to invasive tumor is an important issue for b...
CD44 is known as an adhesion molecule which is involved in lymphocyte activation and lymphocyte homi...
Cancer stem cells (CSCs) have been defined as 'a cell within a tumor that possesses the capacity to ...
Introduction A subpopulation (CD44+/CD24-) of breast cancer cells has been reported to have stem/pr...
Objective: Invasive micropapillary carcinoma of the breast is a distinct variant of breast cancer. I...
<p>A, DAPI; B, DAPI and CD24 (red); C, DAPI and CD44 (green); D, merged images. The composite image ...
This study aimed to identify the CD24 and CD44 immunophenotypes within invasive ductal breast carcin...